Kazuhiro Kitamura

MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting <i>MAGI2</i> in Lung Adenocarcinoma Cells

Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano et al. · Molecular Cancer Therapeutics · 2013 · 186 citations · Full text

Medicine, Cancer Biology, Oncology +17

MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells

Mengru Cao, Masahiro Seike, Chie Soeno et al. · International Journal of Oncology · 2012 · 169 citations · Full text

Life Sciences, Cell Biology, Oncology +17

The Feasibility Study of Carboplatin Plus Etoposide for Advanced Small Cell Lung Cancer with Idiopathic Interstitial Pneumonias

Yuji Minegishi, Hidehiko Kuribayashi, Kazuhiro Kitamura et al. · Journal of Thoracic Oncology · 2011 · 71 citations · Full text

Medicine, Oncology, Pharmacology +8

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation

Akihiko Miyanaga, K Shimizu, Rintaro Noro et al. · BMC Cancer · 2013 · 53 citations · Full text

Medicine, Molecular Biology, Oncology +17

Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion

Kazuhiro Kitamura, Kaoru Kubota, Masahiro Ando et al. · Cancer Chemotherapy and Pharmacology · 2012 · 47 citations

Medicine, Oncology, Pharmacotherapy +14